Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...
A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...
Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.
NEW YORK, NY / ACCESS Newswire / March 11, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers ...
The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a ...
A federal judge has ruled in favor of Merck in litigation accusing the drugmaker of concealing the risks of Gardasil, a ...
In the second trial, which was open label, 95.6% of participants who switched to DOR/ISL maintained viral suppression ...
Dividend-paying stocks are a traditional defensive play, while healthcare faces fewer trade and economic headwinds than most ...
OUSA is an ETF that provides exposure to high-quality U.S. companies that pay regular dividends. The fund tracks the O’Shares ...
A federal judge ruled in Merck & Co.’s favor in a safety lawsuit over its Gardasil vaccine, allowing the drugmaker to ...
Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results